| |
| |
|
| Insider
Information: |
Fratamico Arthur |
| Relationship: |
Director |
| City: |
Burlington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
57,669 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$504,308 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
57,669 |
|
|
| Total
Value |
$504,308 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Flexion Therapeutics Inc |
FLXN |
Officer |
2014-02-11 |
48,054 |
|
0 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
Chief Business Officer |
2016-10-24 |
0 |
2015-08-27 |
0 |
Premium* |
|
|
Panbela Therapeutics, Inc. |
PBLA |
Director |
2021-05-25 |
9,615 |
2020-09-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PBLA |
Panbela Therapeutics, Inc... |
Director |
• • – |
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,316 |
9,615 |
0 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Director |
• • – |
2020-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,875 |
5,299 |
0 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Director |
• • – |
2020-09-01 |
4 |
B |
$0.00 |
$0 |
D/D |
2,424 |
2,424 |
2.31 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Business Officer |
• – – |
2016-10-24 |
4 |
D |
$21.00 |
$277,893 |
D/D |
(13,233) |
0 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Business Officer |
• – – |
2016-04-29 |
4 |
A |
$6.11 |
$12,745 |
D/D |
2,086 |
12,086 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Business Officer |
• – – |
2015-08-27 |
4 |
B |
$7.83 |
$78,266 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Business OfficerOfficer |
• – – |
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
48,054 |
|
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
